A RADIOMETRIC ASSAY FOR HIV-1 PROTEASE

被引:21
作者
HYLAND, LJ
DAYTON, BD
MOORE, ML
SHU, AYL
HEYS, JR
MEEK, TD
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT PEPTIDE CHEM,KING OF PRUSSIA,PA 19406
[2] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
关键词
D O I
10.1016/0003-2697(90)90628-M
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, high-throughput radiometric assay for HIV-1 protease has been developed using ion-exchange chromatography performed in 96-well filtration plates. The assay monitors the activity of the HIV-1 protease on the radiolabeled form of a heptapeptide substrate, [tyrosyl-3,5-3H]Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2, which is based on the p17-p24 cleavage site found in the viral polyprotein substrate Pr55gag. Specific cleavage of this uncharged heptapeptide substrate by HIV-1 protease releases the anionic product [tyrosyl-3,5-3H]Ac-Ser-Gln-Asn-Tyr, which is retained upon minicolumns of the anion-exchange resin AG1-X8. Protease activity is determined from the recovery of this radiolabeled product following elution with formic acid. This facile and highly sensitive assay may be utilized for steady-state kinetic analysis of the protease, for measurements of enzyme activity during its purification, and as a routine assay for the evaluation of protease inhibitors from natural product or synthetic sources. © 1990.
引用
收藏
页码:408 / 415
页数:8
相关论文
共 26 条
  • [1] BILLICH S, 1988, J BIOL CHEM, V263, P17905
  • [2] Cleland W W, 1979, Methods Enzymol, V63, P103
  • [3] Cleland W. W., 1977, ADV ENZYMOL RELAT AR, V29, P1
  • [4] DARKE PL, 1989, J BIOL CHEM, V264, P2307
  • [5] HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS
    DARKE, PL
    NUTT, RF
    BRADY, SF
    GARSKY, VM
    CICCARONE, TM
    LEU, CT
    LUMMA, PK
    FREIDINGER, RM
    VEBER, DF
    SIGAL, IS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) : 297 - 303
  • [6] HUMAN IMMUNODEFICIENCY VIRUS PROTEASE EXPRESSED IN ESCHERICHIA-COLI EXHIBITS AUTOPROCESSING AND SPECIFIC MATURATION OF THE GAG PRECURSOR
    DEBOUCK, C
    GORNIAK, JG
    STRICKLER, JE
    MEEK, TD
    METCALF, BW
    ROSENBERG, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 8903 - 8906
  • [7] THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS
    DIXON, M
    [J]. BIOCHEMICAL JOURNAL, 1953, 55 (01) : 170 - 171
  • [8] INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE INVITRO - RATIONAL DESIGN OF SUBSTRATE-ANALOG INHIBITORS
    DREYER, GB
    METCALF, BW
    TOMASZEK, TA
    CARR, TJ
    CHANDLER, AC
    HYLAND, L
    FAKHOURY, SA
    MAGAARD, VW
    MOORE, ML
    STRICKLER, JE
    DEBOUCK, C
    MEEK, TD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 9752 - 9756
  • [9] AIDS IN 1988
    GALLO, RC
    MONTAGNIER, L
    [J]. SCIENTIFIC AMERICAN, 1988, 259 (04) : 40 - 48
  • [10] ROLE OF CAPSID PRECURSOR PROCESSING AND MYRISTOYLATION IN MORPHOGENESIS AND INFECTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    GOTTLINGER, HG
    SODROSKI, JG
    HASELTINE, WA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) : 5781 - 5785